Business
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
- Four abstracts accepted show the potential of applying gene circuits in multiple cell and gene therapy modalities for neurology, ophthalmology, and oncology
About this update from Senti Biosciences Holdings, Inc.
[{"type":"text","content":"- Four abstracts accepted show the potential of applying gene circuits in multiple cell and gene therapy modalities for neurology, ophthalmology, and oncology - - New preclinical data demonstrate ongoing progress from collaborations with BlueRock and Spark - SOUTH SAN FRANCISCO, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced two oral presentations and two poster presentations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, being held May 16-20, 2023, in Los Angeles, CA. “The abstracts accepted for presentation at ASGCT illustrate the potential and modularity of Senti’s gene circuit platform,” said Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder of Senti Bio. “Our presence at such an important venue this year represents tremendous progress in our wholly-owned and partnered programs, and underlines the incredible work from our research team. The work that will be presented validates the applicability of Senti's technology in modifying a wide range of cells, including NK cells, T cells, AAVs and stem cells, using both viral and non-viral techniques, for a variety of indications including neurology and ophthalmology.” Information about the oral presentations and the poster sessions is as follows: Oral PresentationsEngineering pharmacologically relevant, FDA-approved small-molecule-regulated gene circuits for therapeutic applications in the brainIn collaboration with BlueRock TherapeuticsAbstract Number: 150Location: Room 502 ABDate and Time: May 18, 2023, 3:00 p.m. - 3:15 p.m. PT Massively parallel and systematic engineering platform for highly compact, cell-type specific, and potent Smart Sensor promoters for precision retinal gene therapiesIn collaboration with Spark TherapeuticsAbstract Number: 341Location: Room 502 ABDate and Time: May 20, 2023, 8:15 a.m. - 8:30 a.m. PT Poster PresentationsHigh-throughput engineering of Logic Gated-gene circuits for precision CAR cell therapiesAbstract Number: 1408Session Title: Friday Poster SessionDate and Time: May 19, 2023, 12:00 p.m. PT Designing cell-state-specific synthetic promoters as Smart Sensors to control macrophage polarizationIn collaboration with BlueRock Therape...